We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$5.23B
AUM Growth
+$432M
Cap. Flow
-$77.4M
Cap. Flow %
-1.48%
Top 10 Hldgs %
25.64%
Holding
696
New
43
Increased
170
Reduced
285
Closed
48

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.9M
2
NVDA icon
NVIDIA
NVDA
+$9.88M
3
LVS icon
Las Vegas Sands
LVS
+$9.7M
4
BNY
Bank of New York Mellon
BNY
+$9.63M
5
CSCO icon
Cisco
CSCO
+$8.91M

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Consumer Discretionary 17.32%
3 Healthcare 12.32%
4 Miscellaneous 11.15%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STX icon
476
Seagate
STX
$192B
$411K 0.01%
8,344
+783
+10% +$36.8K
IJK icon
477
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
$407K 0.01%
6,800
PAR icon
478
PAR Technology
PAR
$795M
$405K 0.01%
10,000
-10,000
-50% -$357K
HEI icon
479
HEICO Corp
HEI
$47.1B
$402K 0.01%
3,843
-2,500
-39% -$258K
PHM icon
480
Pultegroup
PHM
$24.1B
$400K 0.01%
8,634
-1,021
-11% -$43.7K
NDSN icon
481
Nordson
NDSN
$18.4B
$397K 0.01%
2,068
-46
-2% -$8.86K
ROKU icon
482
Roku
ROKU
$23.2B
$396K 0.01%
+2,100
New +$332K
LULU icon
483
lululemon athletica
LULU
$13.1B
$395K 0.01%
1,200
-20
-2% -$6.67K
RETA
484
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$390K 0.01%
4,000
FBRX icon
485
Forte Biosciences
FBRX
$1.63B
$388K 0.01%
320
-88
-22% -$58.3K
TGTX icon
486
TG Therapeutics
TGTX
$8.53B
$388K 0.01%
14,500
+2,500
+21% +$57.5K
COP icon
487
ConocoPhillips
COP
$156B
$378K 0.01%
11,515
+1,174
+11% +$44.5K
MO icon
488
Altria Group
MO
$113B
$371K 0.01%
9,603
+3,557
+59% +$148K
CF icon
489
CF Industries
CF
$19B
$367K 0.01%
11,941
+455
+4% +$14.5K
EXPO icon
490
Exponent
EXPO
$3.38B
$367K 0.01%
5,090
TD icon
491
Toronto Dominion Bank
TD
$200B
$365K 0.01%
7,900
TYL icon
492
Tyler Technologies
TYL
$15.1B
$361K 0.01%
1,035
-66
-6% -$22.8K
CHD icon
493
Church & Dwight Co
CHD
$24.3B
$359K 0.01%
3,828
+228
+6% +$20.7K
LII icon
494
Lennox International
LII
$13.5B
$354K 0.01%
1,300
MASI
495
DELISTED
Masimo
MASI
$354K 0.01%
1,500
SGMO
496
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$354K 0.01%
37,440
-1,200
-3% -$13K
JETS icon
497
US Global Jets ETF
JETS
$788M
$353K 0.01%
+20,900
New +$355K
WU icon
498
Western Union
WU
$2.25B
$347K 0.01%
16,197
-5,612
-26% -$127K
HUBB icon
499
Hubbell
HUBB
$24.8B
$342K 0.01%
2,500
TTEK icon
500
Tetra Tech
TTEK
$9.38B
$340K 0.01%
17,780
-1,570
-8% -$27.9K

Similar funds

Tocqueville Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Tocqueville Asset Management held 696 positions worth $5.23B, up 9% from $4.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Tocqueville Asset Management's Q3 2020 filing shows 43 new, 170 increased, 285 reduced and 48 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M. The largest sale was Apple, an estimated $12.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Tocqueville Asset Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M.
  • Tocqueville Asset Management added most to Charles Schwab in Q3 2020, an estimated $18.4M increase.
  • Tocqueville Asset Management's biggest Q3 2020 reduction was Apple, cutting an estimated $12.9M.
  • Tocqueville Asset Management fully exited Las Vegas Sands in Q3 2020, selling an estimated $9.7M.
  • Tocqueville Asset Management's ten largest holdings make up 26% of its $5.23B portfolio in Q3 2020.
  • Tocqueville Asset Management opened 43 new positions and closed 48 in Q3 2020.
  • Tocqueville Asset Management's portfolio value rose 9% quarter-over-quarter to $5.23B.

Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.